Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Hemp Cannabinoid Study topic
No spam. Unsubscribe anytime.
House approves study committee (HR 368) to review hemp-derived cannabinoids and public-safety impacts
Summary
The Agriculture & Consumer Affairs Committee voted to create a study committee under HR 368 to examine intoxicating hemp-derived cannabinoids, their health and safety impacts, and possible regulatory responses; the motion passed by voice vote.
The Agriculture & Consumer Affairs Committee approved HR 368 to form a study committee examining hemp-derived cannabinoids, including delta-8 and other isomers, their effects on public health and safety, and potential regulatory responses.
Representative Saints moved to create the study committee and the motion passed by voice vote. Committee members and witnesses said the topic requires a broad, evidence-based review before further legislation.
Why it matters: Witnesses from public-health groups, law enforcement advocates and the hemp industry said the market for hemp-derived intoxicants has outpaced regulatory frameworks. Proponents argued a study committee could gather scientific data, review other states— approaches and recommend targeted policy.
What supporters told the committee Michael Mumper of Georgians for Responsible Marijuana Policy urged the study to focus on specific questions including intoxication thresholds for new and experienced users, crash risk, workplace impacts and youth exposure. "Can hemp consumables impact driving?" Mumper asked, noting poison-control calls for young children and asserting the need to study isomers such as delta-8, delta-10 and THCA.
Dr. Greg Raducah, a long-time substance-abuse prevention specialist with Georgians for Responsible Marijuana Policy, said a flaw in the 2018 Farm Bill limited regulation to delta-9 THC, enabling other intoxicating isomers to proliferate. He told the committee the study should assess semi-synthetic and synthetic cannabinoids derived from hemp.
Industry and retail testimony Speakers representing hemp firms and retailers said they support a comprehensive study committee but urged neutral language and industry participation on study panels. Joe Salome of Georgia Hemp Company and other retail owners said recent law changes reduced foot traffic and sales and asked that the study fairly consider consumer uses and differential effects by cannabinoid and dose.
Alan Hart of Class Sativa (US Hemp Roundtable affiliate) urged precise definitions for "intoxication" and cannabinoid-specific study, noting that different cannabinoids interact with receptors differently and that some (he said) have little intoxication potential.
Vote and next steps A motion to create the study committee was made, seconded and approved by voice vote in committee. Committee leadership indicated a Senate study committee is moving in parallel and that both bodies would share information; the Department of Agriculture expressed support for a robust study process over the summer.
Speakers and stakeholders requested that study membership include industry representatives, law enforcement, public-health experts, family members affected by product harms and people in recovery.
Ending note: Committee members said the study committee should be transparent and broad-ranging; members asked to be notified of meetings and expressed hope the review will inform future targeted legislation.
